Use of AstraZeneca's coronavirus vaccine has been suspended by health authorities in Denmark, Norway and Iceland after reports of blood clots in some vaccinated people. Austria had previously stopped using the drug because of deaths from pulmonary thromboembolism due to clotting disorders after vaccination. However, the European regulator EMA stated that the benefits of the vaccine outweigh its risks and that it can continue to be used.